Analysis of Partial D Subtypes by Various Anti-D Reagents / 대한수혈학회지
Korean Journal of Blood Transfusion
;
: 152-158, 2007.
Artículo
en Coreano
| WPRIM
| ID: wpr-118886
ABSTRACT
BACKGROUND:
There are some previous reports about partial D in Korea. However, the frequency of the partial D in Korea is still unknown. In this study, subtypes of partial D were analyzed by the use of various commercially available anti-D reagents.METHODS:
We collected 273 cases determined as RhD negative by RhD typing using the tube method with monoclonal IgM/IgG anti-D reagent (Bioscot. Livingston, UK) from 80,062 cases that were screened between January 2004 and August 2007. The cases were divided into three periods (I, II, III), according to the manufacturers and numbers of anti-D reagents used. A weak D test was performed by using the tube method with various anti-D reagents. The cases with different reactivity between anti-D reagents were determined as partial D, and further analyzed the subtypes by reactivity patterns according to the target epitope of anti-D reagents. An additional test using the ID-Partial D Typing Card (DiaMed, Cressier, Switzerland) was conducted during period III.RESULTS:
Five cases showed reactivity patterns of weak D and 16 cases showed reactivity patterns of partial D. Ten cases of partial D were typed as DVI and three cases were typed as DFR. During period III, five cases were typed as DVI and one case was typed as DFR. These results were different from the results obtained with the use of the ID-Partial D Typing Card.CONCLUSION:
DVI, which is the most common subtype of partial D, is also common in Korea. Therefore, RhD typing and a weak D test should be performed using combined anti-D reagents that enable the differentiation of DVI from other subtypes.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Indicadores y Reactivos
/
Corea (Geográfico)
País/Región como asunto:
Asia
Idioma:
Coreano
Revista:
Korean Journal of Blood Transfusion
Año:
2007
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS